
The Government of Ghana has announced plans to establish two specialized pharmaceutical and biomanufacturing hubs in the Eastern and Central Regions. This initiative is designed to boost domestic production of essential medicines and position the country as a central manufacturing node within the West African market. By providing dedicated industrial infrastructure, the state aims to attract both local and international investors, ultimately reducing the nation's heavy reliance on imported pharmaceutical products.
These hubs will offer specialized facilities for a range of activities, including contract manufacturing and large-scale health product production. Dr. Brempong noted that the initiative will focus on creating a conducive environment for Research and Development (R&D), allowing pharmaceutical companies to innovate and scale their operations. The centralized nature of these hubs is expected to address existing logistical challenges and lower the cost of production for participating firms through shared infrastructure.
Beyond the immediate manufacturing goals, the project is viewed as a strategic move to enhance regional health security and stimulate local economic growth. By establishing these centers in the Eastern and Central Regions, the government expects to create new jobs and foster industrialization in these areas. This development aligns with the broader national strategy to leverage the African Continental Free Trade Area (AfCFTA), enabling Ghana to become a key supplier of pharmaceutical products across the continent.